Vitamin D receptor gene polymorphism in patients with aseptic necrosis of the femoral head: a comparative cross-sectional study
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20262017Keywords:
Vitamin D receptor gene, Polymorphism, Aseptic necrosis, Femoral head, Hip osteoarthritis, Vitamin D deficiencyAbstract
Background: This study explored the correlation of the Met1Thr (rs2228570) polymorphism of the vitamin D receptor (VDR) gene with aseptic necrosis of the femoral head (ANFH).
Methods: This comparative cross-sectional study consisted of 74 patients divided into group 1 of 44 patients with ANFH and group 2 of 30 patients with hip osteoarthritis stage 3 by Kellgren-Lawrence classification. The VDR genotyping was conducted on venous blood samples. Serum vitamin D3 and osteocalcin were quantified via enzyme immunoassays. Statistical analyses consisted of χ² tests for genotype distribution and Mann-Whitney U-tests for biochemical parameters, considering for non-normal distributions.
Results: There were no statical significant differences were observed in Met1Thr genotype distribution between ANFH and osteoarthritis groups (χ²=2.081; p=0.353). The carriers of the G (Thr) allele revealed a non-significant pattern toward elevated ANFH risk (OR=2.16; 95% CI 0.74-6.31). Both groups showed severe vitamin D deficiency (median 25(OH)D<30 ng/ml) and significantly reduced osteocalcin levels, reflecting reduced bone turnover rate. No statistically significant differences in Vitamin D3 or osteocalcin levels were noted between groups.
Conclusions: Severe vitamin D deficiency and suppressed osteoblastic activity distinguished both ANFH and osteoarthritis. Although the Met1Thr VDR polymorphism was more common in ANFH patients, its connection with disease risk was not statistically significant. These findings suggest vitamin D deficiency as a key risk factor and highlight further research on VDR polymorphisms in larger cohorts.
References
Vicaș RM, Bodog FD, Ciursaș AN, Fugaru OF, Grosu F, Lazăr L, et al. Aseptic necrosis of femoral head: clinical study. Curr Health Sci J. 2021;47(2):228-36.
Konarski W, Poboży T, Śliwczyński A, Kotela I, Krakowiak J, Hordowicz M, et al. Avascular necrosis of femoral head—overview and current state of the art. Int J Environ Res Public Health (IJERPH). 2022;19(12):7348.
Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev. 2019;4(3):85-97.
Gu B, Yao F, Peng P, Zeng Z, He W, Wei Q. Global incidence of osteonecrosis of the femoral head after femoral neck fracture surgery in adolescents: a meta-analysis. J Orthop Surg Res. 2024;19(1):791.
Choi HR, Steinberg ME, Cheng EY. Osteonecrosis of the femoral head: diagnosis and classification systems. Curr Rev Musculoskelet Med. 2015;8(3):210-20.
Seamon J, Keller T, Saleh J, Cui Q. The pathogenesis of nontraumatic osteonecrosis. Arthritis. 2012;2012:1-11.
Kumar P, Rathod PM, Aggarwal S, Patel S, Kumar V, Jindal K. Association of specific genetic polymorphisms with atraumatic osteonecrosis of the femoral head: a narrative review. J Orthop Assoc India (JOIO). 2022;56(5):771-84.
Elhoseiny SM, Morgan DS, Rabie AM, Bishay ST. Vitamin D receptor (VDR) gene polymorphisms (FokI, BsmI) and their relation to vitamin D status in pediatric β-thalassemia major. Indian J Hematol Blood Transfus. 2016;32(2):228-38.
Rochel N. Vitamin D and its receptor from a structural perspective. Nutrients. 2022;14(14):2847.
Usategui-Martín R, De Luis-Román DA, Fernández-Gómez JM, Ruiz-Mambrilla M, Pérez-Castrillón JL. Vitamin D receptor (VDR) gene polymorphisms modify the response to vitamin D supplementation: a systematic review and meta-analysis. Nutrients. 2022;14(2):360.
Alkhzouz C, Cabau G, Lazea C, Asavoaie C, Bucerzan S, Mirea AM, et al. Skeletal abnormalities and VDR1 gene polymorphisms in mucopolysaccharidosis patients. Pharmacogenomics Pers Med (PGPM). 2021;14:349-58.
Kaneko A, Urnaa V, Nakamura K, Kizuki M, Seino K, Inose T, et al. Vitamin D receptor polymorphism among children with rickets in Mongolia. J Epidemiol. 2007;17(1):25-9.
Marozik PM, Tamulaitiene M, Rudenka E, Alekna V, Mosse I, Rudenka A, et al. Association of vitamin D receptor gene variation with osteoporosis risk in Belarusian and Lithuanian postmenopausal women. Front Endocrinol (Lausanne). 2018;9:305.
Banjabi AA, Al-Ghafari AB, Kumosani TA, Kannan K, Fallatah SM. Genetic influence of vitamin D receptor gene polymorphisms on osteoporosis risk. Int J Health Sci (Qassim). 2020;14(4):22-8.
Hu K, Olsen BR. The roles of vascular endothelial growth factor in bone repair and regeneration. Bone. 2016;91:30-8.
Wacker M, Holick MF. Vitamin D—effects on skeletal and extraskeletal health and the need for supplementation. Nutrients. 2013;5(1):111-48.
Abdollahi S, Taheri F, Lahijan ASN, Shoga SH, Didehban A, Doaei S. Genetics and vitamin D interactions in osteoporosis: a path to precision medicine. J Cell Mol Med. 2025;29(16):e70780.
Downloads
Published
How to Cite
Issue
Section
